Skip to main content
SpringerLink
Log in

Prinzipien der systemischen Chemotherapie einschließlich Hormontherapie

  • Chapter
Chirurgische Onkologie

Part of the book series: Die Praxis der Chirurgie ((PRAXCHIR))

  • 38 Accesses

Zusammenfassung

Die medikamentöse Behandlung (Zytostatika, Hormone) hat heute neben Operation und Strahlentherapie einen festen Platz in der Behandlung bösartiger Krankheiten. Die genannten Therapiemodalitäten stehen nicht in Konkurrenz zueinander, der Tumor selbst, seine Art und Ausbreitung bestimmen das therapeutische Vorgehen, das in vielen Fällen interdisziplinär festgelegt werden sollte. Für dieses interdisziplinäre Gespräch ist es notwendig, Fakten und Konzepte der Nachbardisziplinen zur Kenntnis zu nehmen. Dabei sollen praktische Aspekte im Vordergrund stehen, gewisse Verallgemeinerungen sind unvermeidlich.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Cancer Society (1977) Cancer facts and figures. American Cancer Society, New York

    Google Scholar 

  • Axtell LM, Sire AJ, Myers MH (eds) (1976) Cancer patient survival report No 5; Cancer surveillance, epidemiology and end results (SEER) program. National Cancer Institute, NIH, US-DHEW Publ. No. (NIH), pp 77–992

    Google Scholar 

  • Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambrilla C, Marchini S, Veronesi U (1981) Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: The Milan Institute experience. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune & Stratton, New York, pp 435–444

    Google Scholar 

  • Bruntsch U (1982) Entwicklung und Erprobung neuer Medikamente in der Onkologie. MMW 124:356–360

    CAS  Google Scholar 

  • Bruntsch U, Kappauf H, Theissing J, Gallmeier WM (1982) Plattenepithelcarcinome im HNO-Bereich: Chemotherapie. MMW 124:209–212

    CAS  Google Scholar 

  • Buzdar A, Smith T, Blumenschein G, Hortobagyi G, Hersh E, Gehan E (1981) Adjuvant chemotherapy with fluoro-uracil, doxorubicin, and cyclophosphamide (FAC) for stage II or III breast cancer: Five-year results. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune & Stratton, New York, pp 419–426

    Google Scholar 

  • DeVita VT Jr (1981) Recent perspectives on the development of drug resistance and some more good news. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune & Stratton, New York, pp 3–11

    Google Scholar 

  • De Vita VT (1982) Principles of chemotherapy. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology. Lippincott, Philadelphia Toronto, p 132

    Google Scholar 

  • Fisher B, Redmond C, Womark N and participating NSABP investigators (1981) Breast cancer studies of the NSABP: An editorialized overview. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune & Stratton, New York, pp 359–369

    Google Scholar 

  • Frei E, Canellos GP (1980) Dose: A critical factor in cancer chemotherapy. Am J Med 69:585–594

    Article  PubMed  Google Scholar 

  • Frei E, Jaffe N, Link M, Abelson H (1979) Adjuvant chemotherapy of osteogenic sarcoma: Progress, problems and prospects. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer II. Grune & Stratton, New York, pp 355–373

    Google Scholar 

  • Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727–1731

    PubMed  CAS  Google Scholar 

  • Hutchinson DJ, Schmid FA (1973) Cross-resistance and collateral sensitivity. In: Mihich E (ed) Drug resistance and selectivity. Academic Press, New York, p 73

    Google Scholar 

  • Legha S, Muggia FM (1976) Antiestrogens in the treatment of cancer. Ann Intern Med 84:751

    PubMed  CAS  Google Scholar 

  • Lippman M (1982) Principles of hormonal therapy. In: Carter SK, Glatstein E, Livingston RB (eds) Principles of cancer treatment. McGraw-Hill, New York, pp 146–152

    Google Scholar 

  • Maass H, Engel B, Trams G, Nowakowski H, Stolzenbach G (1975) Steroid hormone receptors in human breast cancer and the clinical significance. J Steroid Biochem 6:743–749

    Article  PubMed  CAS  Google Scholar 

  • Maillot K von, Gentsch HH, Gunselmann W (1980) Steroid receptors and response to endocrine treatment and chemotherapy of advanced breast cancer. J Cancer Res Clin Oncol 98:301–313

    Article  Google Scholar 

  • Mendelsohn ML (1960) The growth fraction: A new concept applied to tumors. Science 132:1496

    Google Scholar 

  • Senn HJ (1981) Adjuvante Chemotherapie beim Mammakarzinom. Dtsch Med Wochenschr 106:1626–1630

    Article  PubMed  CAS  Google Scholar 

  • Schabel FM Jr, Simpson-Herren L (1978) Some variables in experimental tumor systems which complicate interpretation of data from in vivo kinetic and pharmacological studies with anticancer drugs. Antibiot Chemother 23:113–127

    PubMed  Google Scholar 

  • Skipper HE (1979) Historic milestones in cancer biology: A few that are important in cancer treatment (revisited). Semin Oncol 6:506–514

    PubMed  CAS  Google Scholar 

  • Skipper HE, Schabel FM, Wilcox WS (1964) Experimental evaluation of potential anticancer agents XIII, on the criteria and kinetics associated with curability of experimental leukemia. Cancer Chemother Rep 35:1–111

    PubMed  CAS  Google Scholar 

  • Tannock I (1978) Cell kinetics and chemotherapy: A critical review. Cancer Chemother Rep 62:1117–1133

    CAS  Google Scholar 

  • Tormey DC, Holland JF, Weinberg V et al. (1981) 5-drug versus 3-drug ± MER postoperative chemotherapy for mammary carcinoma. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune & Stratton, New York, pp 377–384

    Google Scholar 

Weiterführende Literatur

  • Brunner KW, Nagel GA (eds) (1985) Internistische Krebstherapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Carter SK, Glatstein E, Livingston RB (eds) (1982) Principles of cancer treatment. McGraw-Hill, New York

    Google Scholar 

  • DeVita VT Jr, Hellman S, Rosenberg SA (eds) (1985) Cancer principles and practice of oncology. Lippincott, Philadelphia Toronto

    Google Scholar 

  • Gallmeier WM, Bruntsch U, Röttinger EM, Betzler M (eds) (1980, 1982, 1983, 1984, 1985) Praktische Onkologie. MMW Medizin Verlag, München

    Google Scholar 

  • Gross R, Schmidt CG (eds) (1985) Klinische Onkologie. Thieme, Stuttgart New York

    Google Scholar 

Download references

Authors
  1. W. M. Gallmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgische Klinik der Universität Erlangen-Nürnberg, Maximiliansplatz, 8520, Erlangen, Deutschland

    Franz Paul Gall (Prof. Dr. med.) (Prof. Dr. med.)

  2. Abteilung für Klinische Pathologie, Chirurgische Universitätsklinik, Maximiliansplatz, 8520, Erlangen, Deutschland

    Paul Hermanek (Prof. Dr. med.) (Prof. Dr. med.)

  3. Chirurgische Abteilung, Städtisches Krankenhaus, Spitalstraße 4, 8550, Forchheim, Deutschland

    Jürgen Tonak (Priv.-Doz. Dr. med.) (Priv.-Doz. Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Gallmeier, W.M. (1986). Prinzipien der systemischen Chemotherapie einschließlich Hormontherapie. In: Gall, F.P., Hermanek, P., Tonak, J. (eds) Chirurgische Onkologie. Die Praxis der Chirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69600-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69600-8_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69601-5

  • Online ISBN: 978-3-642-69600-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation